KeyBank National Association
GMAB icon

KeyBank National Association’s Genmab GMAB Stock Holding History

KeyBank National Association’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$853K Buy
31,068
+538
+2% +$14.3K ﹤0.01% 700
2026
Q1 		$819K Sell
30,530
-5,204
-15% -$156K ﹤0.01% 647
2025
Q4 		$1.1M Buy
35,734
+1,027
+3% +$32K ﹤0.01% 562
2025
Q3 		$1.06M Buy
34,707
+5,843
+20% +$142K ﹤0.01% 564
2025
Q2 		$596K Buy
28,864
+295
+1% +$6.06K ﹤0.01% 710
2025
Q1 		$559K Buy
28,569
+125
+0.4% +$2.62K ﹤0.01% 721
2024
Q4 		$594K Buy
28,444
+89
+0.3% +$1.96K ﹤0.01% 720
2024
Q3 		$691K Sell
28,355
-2,192
-7% -$58.6K ﹤0.01% 663
2024
Q2 		$768K Sell
30,547
-1,041
-3% -$29.5K ﹤0.01% 606
2024
Q1 		$945K Sell
31,588
-599
-2% -$17.6K ﹤0.01% 552
2023
Q4 		$1.02M Sell
32,187
-545
-2% -$17.1K ﹤0.01% 514
2023
Q3 		$1.15M Buy
+32,732
New +$1.25M 0.01% 442

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

KeyBank National Association's GMAB Position: Q2 2026 in Review

KeyBank National Association increased its Genmab (GMAB) stake by 1.8% in Q2 2026, buying an estimated $14.3K and bringing the position to 31,068 shares worth $853K. The position accounts for ﹤0.01% of the portfolio, ranked #700.

KeyBank National Association first reported a position in GMAB in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.15M in Q3 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • KeyBank National Association held 31,068 shares of Genmab worth $853K as of Q2 2026.
  • KeyBank National Association bought 538 Genmab shares in Q2 2026, an estimated $14.3K.
  • Genmab made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #700 holding.
  • KeyBank National Association first reported a position in Genmab in Q3 2023 and has held it in 12 quarters since.
  • KeyBank National Association's Genmab position peaked at $1.15M in Q3 2023.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.